(Recording) Ancillary Symposium - Improving Outcomes in Acromegaly: Let Your Patients Be Your Guide

Did you attend the live session during ENDO Online? Please navigate to this course page to complete the evaluation.
 
This course was a virtual live CME-certified Ancillary Symposium presented at ENDO Online 2020. This activity is supported by an educational grant from Chiasma, Inc. This ancillary symposium is developed through the Endocrine Society’s Special Programs Committee (SPC).
 
Educational Partner: Vindico Medical Education

PLEASE REGISTER THEN CLICK "START" TO: 

  • EVALUATE SESSIONS 

  • CLAIM CME 

  • DOWNLOAD PRESENTATION SLIDES 

  • PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION 

Target Audience

This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals. 

Learning Objectives

Upon completion of this educational activity, learners will be able to: 

  • Assess the pathophysiology and clinical symptomology associated with acromegaly to improve patient recognition and diagnosis
  • Examine common comorbidities associated with acromegaly and the burden on patient quality of life despite endocrine control
  • Review the latest clinical evidence regarding emerging treatments for the management of patients with acromegaly
  • Evaluate the importance of communicating with patients regarding their disease state and realistic treatment expectations

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Neuroendocrinology and Pituitary
Level of Outcomes: 
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 1.50 ABIM MOC
  • 1.50 AMA PRA Category 1 Credits™
  • 1.50 CME Certificate of Participation
Course opens: 
07/13/2020
Course expires: 
07/13/2021
Rating: 
0

Through didactic presentations and challenging case scenarios, this program will provide an opportunity to address the pathophysiology and clinical symptomology, examine common comorbidities, review treatment options associated with acromegaly and encourage health care professionals to change their practice behaviors to improve their patients’ health. This symposium is certified for 1.5 AMA PRA Category 1 Credits™ and 1.5 ABIM MOC points.

 

FACULTY

Adriana G. Ioachimescu, MD, PhD- Program Chair 
Professor
Emory University
Co-Director
The Emory Pituitary Center
Consulting Editor
Endocrinology and Metabolism Clinics
Atlanta, GA
 
Lisa B. Nachtigall, MD
Clinical Director
Massachusetts General Hospital
Associate Professor
Harvard Medical School
Boston, MA
 
Shlomo Melmed, MD 
Professor and Dean
Cedars Sinai Medical Center
Los Angeles, Ca
 

STATEMENT OF INDEPENDENCE

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable. 

The following faculty reported no relevant financial relationships during the content development process for this activity:  
  • Adriana G. Ioachimescu, MD, PhD: Research Investigator Novartis Pharmaceuticals, Chiama, Inc., Strongbridge
  • Lisa B. Nachtigall, MD: Advisory Board Member Spouse, Pfizer, Inc., Corcept; Consultant, Pfizer, Inc.; Grant,  Ipsen; Research Investigator, Chiasma
  • Shlomo Melmed, MD: Advisory Board Member, Chiasma, Inc; Consultant, Ionis, Midatech, Crinetics, Rami, Ipsen; Research Grant, Pfizer, Inc.
The following Special Programs Committee member who planned and reviewed content for this activity reported relevant financial relationships:  
  • Andjela T. Drincic, MD: Advisory Board Member, Corcept  
 
The following Special Programs Committee members reported financial relationships: 
  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca 
  • Angela M. Leung, MD: Speaker,Medical Education Resources, MCE Conferences
  • Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck    

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.  

The following Special Programs Committee members reported no relevant financial relationships: 
  • Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD, Savitha Subramanian, MD;  Soleymani Taraneh, MD; Steven Weitzman, MD 

The following Vindico Medical Education staff reported no relevant financial relationships:

  • Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP; Jennifer Frederick, PharmD, BCPS; Katie Robinson, PhD, CHCP

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
 

DISCLAIMER

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

Use of professional judgment: 
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available. 
Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

COMMERCIAL SUPPORT

This educational activity is supported by an independent medical educational grant from Chiasma, Inc.

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™ and 1.5 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to: 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact. 

REVIEW YOUR DIPLOMATE ABIM ID NUMBER(S)

In order to earn and claim credit, you must:

  1. Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):

    Your ABIM Number: *

    *If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.

  2. Update Profile

Available Credit

  • 1.50 ABIM MOC
  • 1.50 AMA PRA Category 1 Credits™
  • 1.50 CME Certificate of Participation

Did you attend the live session during ENDO Online? Please navigate to this course page to complete the evaluation.